Clinical trial

The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function

NCT03240328

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2017-10-04

PhasePHASE1

Study timeline

Study start (actual)2017-10-04Date precision: day

Registry last updated2022-09-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV/AIDSunresolved

Interventions

CAR-T cellsBIOLOGICAL

Sponsors & collaborators

Guangzhou 8th People's Hospitallead sponsor

Sun Yat-sen Universitycollaborator

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03240328 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.